Business · 22/01/2018Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Device Approvals with Approved, Marketed Drugs
Summary
The FDA is reopening the comment period for a public hearing on device sponsor marketing authorization for new uses with approved, marketed drugs, following a request for an extension to allow more time for public comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →